Literature DB >> 3631924

Giant axonal neuropathy: correlation of clinical findings with postmortem neuropathology.

C Thomas, S Love, H C Powell, P Schultz, P W Lampert.   

Abstract

We report the clinical and postmortem neuropathological findings in a case of long-standing giant axonal neuropathy. The patient, a caucasian male with kinky hair, was first seen at 4 years of age because of increasing unsteadiness of gait. Clinical examination showed nystagmus, cerebellar ataxia, distal sensory loss, and weakness. A sural nerve biopsy at 8 years of age revealed giant axonal neuropathy. The patient became increasingly demented and was incapacitated by weakness and ataxia; he died at 18 years of age. Histological examination of the brain and spinal cord showed numerous Rosenthal fibers, a distal axonopathy that most severely affected the corticospinal tracts, middle cerebellar peduncles, and posterior columns, and olivocerebellar degeneration.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3631924     DOI: 10.1002/ana.410220118

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

1.  Intermediate filament protein accumulation in motor neurons derived from giant axonal neuropathy iPSCs rescued by restoration of gigaxonin.

Authors:  Bethany L Johnson-Kerner; Faizzan S Ahmad; Alejandro Garcia Diaz; John Palmer Greene; Steven J Gray; Richard Jude Samulski; Wendy K Chung; Rudy Van Coster; Paul Maertens; Scott A Noggle; Christopher E Henderson; Hynek Wichterle
Journal:  Hum Mol Genet       Date:  2014-11-04       Impact factor: 6.150

2.  Selective presence of ubiquitin in intracellular inclusions.

Authors:  V Manetto; F W Abdul-Karim; G Perry; M Tabaton; L Autilio-Gambetti; P Gambetti
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

3.  Giant axonal neuropathy: clinical and genetic study in six cases.

Authors:  E Demir; P Bomont; S Erdem; L Cavalier; M Demirci; G Kose; S Muftuoglu; A N Cakar; E Tan; S Aysun; M Topcu; P Guicheney; M Koenig; H Topaloglu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

4.  Giant axonal neuropathy (GAN): an immunohistochemical and ultrastructural study report of a Latin American case.

Authors:  A L Taratuto; G Sevlever; M Saccoliti; L Caceres; M Schultz
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  3T MR with diffusion tensor imaging and single-voxel spectroscopy in giant axonal neuropathy.

Authors:  Christiana Brenner; Carlos Eduardo Speck-Martins; Luciano Farage; Peter B Barker
Journal:  J Magn Reson Imaging       Date:  2008-07       Impact factor: 4.813

Review 6.  Dysfunctions of neuronal and glial intermediate filaments in disease.

Authors:  Ronald K H Liem; Albee Messing
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

7.  Intermediate filament aggregates cause mitochondrial dysmotility and increase energy demands in giant axonal neuropathy.

Authors:  Eitan Israeli; Dilyan I Dryanovski; Paul T Schumacker; Navdeep S Chandel; Jeffrey D Singer; Jean P Julien; Robert D Goldman; Puneet Opal
Journal:  Hum Mol Genet       Date:  2016-03-21       Impact factor: 6.150

8.  Recommendations to enable drug development for inherited neuropathies: Charcot-Marie-Tooth and Giant Axonal Neuropathy.

Authors:  Lori Sames; Allison Moore; Renee Arnold; Sean Ekins
Journal:  F1000Res       Date:  2014-04-03

9.  The role of gigaxonin in the degradation of the glial-specific intermediate filament protein GFAP.

Authors:  Ni-Hsuan Lin; Yu-Shan Huang; Puneet Opal; Robert D Goldman; Albee Messing; Ming-Der Perng
Journal:  Mol Biol Cell       Date:  2016-10-26       Impact factor: 4.138

10.  Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort.

Authors:  Diana X Bharucha-Goebel; Gina Norato; Dimah Saade; Eduardo Paredes; Victoria Biancavilla; Sandra Donkervoort; Rupleen Kaur; Tanya Lehky; Margaret Fink; Diane Armao; Steven J Gray; Melissa Waite; Sarah Debs; Gilberto Averion; Ying Hu; Wadih M Zein; A Reghan Foley; Minal Jain; Carsten G Bönnemann
Journal:  Brain       Date:  2021-11-29       Impact factor: 15.255

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.